Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice

Current schistosomiasis control strategies are mainly based on chemotherapy, but the development of a vaccine against this parasitic disease would contribute to a long-lasting decrease in disease spectrum and transmission. When it comes to vaccine candidates, several genes encoding Schistosoma manso...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Morais, Suellen B., Figueiredo, Barbara C., Assis, Natan R. G., Homan, Jane, Mambelli, Fábio S., Bicalho, Rodrigo M., Souza, Cláudia, Martins, Vicente P., Pinheiro, Carina S., Oliveira, Sergio C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2018
Aiheet:
Immunology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6077287/
https://ncbi.nlm.nih.gov/pubmed/30105029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01762
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia